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ABSTRACT  The molecules  involved  in  Ca2+-dependent cell-cell  adhesion  systems  (CDS)  in  mouse 
hepatocytes were characterized  and compared  with those in teratocarcinoma  cells.  Fab fragments 
of antibody raised against liver tissues (anti-liver) inhibited Ca2+-dependent aggregation of both liver 
and teratocarcinoma cells. A monoclonal antibody raised against teratocarcinoma CDS (ECCD-1) also 
inhibited the Ca2+-dependent aggregation of these two cell types equally. These antibodies induced 
disruption of cell-cell adhesion in monolayers of hepatocytes. Thus, CDS in these two cell types are 
not immunologically  distinctive.  Immunochemical  analyses with these antibodies showed that CDS 
in both hepatocytes and teratocarcinoma cells  involved  at least two classes of cell surface  proteins 
with molecular weights of 124,000 and  104,000.  ECCD-1 selectively  bound to hepatocytes  but not 
to fibroblastic cells in liver cell cultures. Thus, the molecular constitution of CDS in hepatocytes and 
teratocarcinoma stern cells  is identical. As ECCD-1  reacts with other classes of embryonic and fetal 
cells, the molecules identified  here could have a major role in cell-cell adhesion in various tissues at 
any developmental  stage of animals. 
Cell-cell adhesion is a fundamental process in the construction 
of multicellular animals, and a number of studies have been 
undertaken to elucidate its molecular mechanisms. A series 
of experiments from this and other laboratories has revealed 
that a single cell is provided with multiple cell-cell  adhesion 
systems, classified into Ca2+-dependent and Ca2+-independent 
(see reference 1 for review). Our recent studies have focused 
on the identification of molecules involved in Ca2÷-dependent 
cell-cell  adhesion  systems (CDS),  and  have implicated the 
presence a cell surface protein (p140) in CDS of teratocarci- 
noma cells (2, 3). This protein displays a unique Ca2+-sensitive 
property in  that  it  is  digested  by  treatment  with  various 
proteases in the absence of Ca  2+ but not digested when the 
protease  solutions  contain  Ca  2+  (3).  This  property is  well 
correlated with the often reported protease-sensitivity of CDS. 
We confirmed the above observation using a monoclonal 
antibody, ECCD-1, which causes disruption of cell-cell adhe- 
sion in monolayers of teratocarcinoma cells when added to 
cultures, specifically inhibiting the function of CDS (C. Yosh- 
ida-Noro, N. Suzuki, and M. Takeichi, manuscript submit- 
ted). Immunochemical studies revealed that ECCD-I recog- 
nizes multiple cell surface proteins, among which p 140 was a 
Abbreviations  used  in  this  paper:  CDS,  Ca2+-dependent  cell-cell 
adhesion systems; HCMF, N-2-hydroxylethylpiperazine-N'-2-ethane 
sulfonic acid; HBSS, HCMF supplemented with 2  mM CaCI~ and  1 
mM MgCI2. 
major antigen. The molecular weight ofp 140 was determined 
to be ~  124,000  in the study with ECCD-1, although it was 
formerly reported to be 140,000  (3). 
We also showed that ECCD-1  reacts with not only terato- 
carcinoma cells and early embryonic cells but also with certain 
types of differentiated epithelial cells such as hepatocytes and 
epidermal  cells.  In  the  present  study,  we  investigated  the 
properties of CDS  in  mouse hepatocytes, and  showed that 
hepatocytes are provided with the same Ca2+-dependent cell- 
cell adhesion molecules as teratocarcinoma cells,  suggesting 
that  these  molecules are  of general  importance to  cell-cell 
adhesion  in  a  variety of tissues reactive with  ECCD-I  (C. 
Yoshida-Noro, N. Suzuki, and M. Takeichi, manuscript sub- 
mitted). 
MATERIALS  AND  METHODS 
Saline  Solutions  and  Cell  Lines Used:  The following  saline 
solutions were used: Ca  2+- and MgP+-free Puck's saline buffered to pH 7.4 with 
N-2-hydroxylethyl piperazine-N'-2-cthane  sulfonic  acid  (HCMF)  (4),  and 
HCMF supplemented with  2  mM CaC12 and  1 mM MgCI2 (HBSS).  Two 
teratocarcinoma cell lines, AT805 (2) and F9 (5) were  used. Both lines were 
maintained in Dulbccco's modified Eagle's minimal essential medium supple- 
mented with 10% fetal calf serum (DEM- 10F). 
Primary  Cultures  of Fetal Mouse Liver:  To study  the adhesive 
behavior of hepatocytes, we first attempted to use cell suspensions  prepared by 
treating freshly collected  liver tissues with protease solutions. We found, how- 
ever, that this preparation contained numerous blood cells, which could inter- 
fere with hepatocyte adhesion. To eliminate these blood cells and also to enrich 
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Livers were collected  from ICR mouse fetuses of 15 to 17 days post coitus. 
After mincing with scissors, the tissue fragments  were incubated in 0.5% crude 
trypsin (1:250;  Difco Laboratories, Detroit, MI) in HCMF supplemented with 
1 mM ethylene diamine tetraaeetic acid for 30 rain at 37°C, and dissociated 
into small cell clusters or single cells by pipetting. After eentrifugation at 70 g 
for 1 rain, the pellet was dispersed by pipetting and inoculated with DEM-10F 
into plastic culture dishes precoated with rat tendon collagen.  After overnight 
incubation at 37°C, cells floating or attached loosely to the upper surface of 
hepatocytes (mainly blood cells) were removed by rinsing the cultures with 
HBSS.  About  80%  of the cells  remaining attached directly to  the culture 
substratum were hepatocytes (liver parenchymal cells), as judged by morpho- 
logical and immunohistochemical observations. These cultures were used for 
further experiments. 
Antibodies:  Antibody against fetal mouse  liver (anti-liver) was prepared 
as follows.  Fetal mouse livers were mixed with an equal volume of Freund's 
complete adjuvant, and homogenized by a Homo blender (Sakuma Seisakusho, 
Tokyo). About 5 ml of  this sample was injected subcutaneously  along the back 
of  a rabbit.  3 wk later, the liver tissue mixed with Freund's incomplete adjuvant 
was injected.  This injection was repeated five times at weekly intervals. 7 d 
after the last injection, antiserum was collected and heat-inactivated before use. 
Fab fragments of anti-liver IgG (anti-liver Fab) were prepared as described (6) 
and the final preparation was dialyzed against HBSS. 
ECCD-1, a monoclonal antibody recognizing CDS in teratocarcinoma cells, 
was raised in our laboratory (C. Yoshida-Noro, N. Suzuki, and M. Takeichi, 
manuscript submitted). The hybridoma clone producing this antibody was 
obtained by fusion of mouse myeloma P3-X63-Ag8 cells and lymphocytes  of  a 
rat that received injections of  F9 cells; ECCD-1 was recognized by anti-rat IgG. 
Antibody in the culture supernatant of the hybridoma producing ECCD-1  was 
precipitated by 50% saturation of  ammonium  sulphate and dissolved in HBSS, 
the volume of which was adjusted to 1/20 of the original volume. This sample 
was dialyzed against HBSS. 
Protease Treatments of Cells:  Teratocarcinoma cells  were har- 
vested by trypsin treatments leaving CDS intact or inactivating CDS as follows. 
Ceils with intact CDS  were  collected  by treatment with 0.01%  crystallized 
trypsin (Type 1, Sigma Chemical Company, St. Louis, MO) and 1 mM CaCi2 
in HCMF (denoted TC-treatment), and cells without CDS were collected  by 
treatment with 0.01% crystallized trypsin and 1 mM EGTA in HCMF (denoted 
TE-treatment), as described previously (2, 3). Trypsin was replaced with 0.01% 
pronase in the above solution when used to dissaggregate teratocarcinoma cells 
for the aggregation experiments. 
Liver cells cultured overnight were harvested by TC- or TE-treatment for 30 
rain at 37"C. For some aggregation experiments, liver cells were first treated 
with 0.05% collagenase (Type I, Sigma Chemical Co.) in HCMF supplemented 
with 5 mM CaCI2 at 37°C for 15 min, then crystallized  trypsin was added to 
make a  final concentration of 0.01%, followed  by further incubation for  15 
rain. Treated cells were rinsed three times with 0.05% soybean trypsin inhibitor 
(Sigma Chemical Co.) in HCMF supplemented with 1 mM CaC12. After two 
further washings  with HCMF, the cells were dissociated by pipetting in HCMF. 
All steps for rinsing cells were carried out at 4°C. 
Aggregation Assay and Radiolabeling of Cells:  To examine 
the aggregation of dissociated cells, 5 x  104 cells in 0.5 ml of HCMF, supple- 
mented with  1 mM CaCl2 and/or antibodies when neeessary, were  put into 
each well of a Linbro 24-well flat bottom plate (76-033-05,  Flow Laboratories, 
McLean, VA) that had been coated with 1% bovine serum albumin in HCMF, 
and incubated on a gyratory shaker (70 rpm) at 37"C. Cells in preconfluent 
cultures were washed with methionine-free Eagle's minimal essential medium 
and incubated overnight with 40-100 #Ci/ml of  [aSS]methionine in methionine- 
free Eagle's minimal  essential medium supplemented  with 10% fetal calf  serum. 
The labeled cells were used for immunoprecipitation experiments. 
Immunoprecipitation  of Ceil Surface Antigens:  Cells in cul- 
tures or harvested with trypsin were rinsed three times with HBSS and then 
incubated with  10% anti-liver in HBSS at 4°C  for  I  h. After removing the 
antibody solution, the cells were rinsed at least five times with HBSS. The cells 
were  then solubilized with 0.5%  SDS  in  l0  mM Tris-HCl (pH  7.5)  (in a 
minimum  amount), followed by the addition of  an equal volume  of  2% Nonidet 
P-40 (NP40) in 10 mM Tris-HCl (pH 7.5). These detergent solutions contained 
I mM phenylmethylsulfonyl  fluoride,  l mM p-tosyl-L-arginine  methyl ester, l 
mM CaCl2, and 1 mM MgCl2. Then l0 u/ml of deoxyribonuclease I (DN-CL, 
Sigma Chemical Co.) were  added. To this preparation, heat-inactivated and 
formalin-fixed Staphylococcus  aureus (Pansorbin, Calbiochem-Behring Corp. 
LaJolla,  CA) was added (~20 #l of Pansorbin pellet per sample collected from 
a  10-cm dish) and incubated for 1 h at 4°C. The Pansorbin was then washed 
several times with a l:l mixture of the above SDS and Nonidet P-40 solutions, 
once with 62.5  mM Tris-HCl (pH 6.8),  and the sample prepared for electro- 
phoresis. 
Electrophoretic Analysis of the  Immunoprecipitates:  The 
antigen-antibody complexes were released from the Pansorbin by boiling for 3 
min in 2%  SDS,  5%  fl-mereaptoethanol, 10% glycerol,  0.002% bromphenol 
blue  in  62.5  mM  Tris-HCl  (oH  6.8)  and  analyzed  by  SDS-PAGE  using 
Laemmli's  method (7). 35S-labcled antigens separated in the gels were detected 
by fluorography as descdbcd elsewhere (8). 
To detect molecules reacting with the monoclonal antibody ECCD-I, cell 
surface antigens reactive  with anti-liver were collected  and electrophoresed as 
above, and transferred electrophoretically to a nitrocellulose sheet (BA85, 0.45 
#m, Schleicher and Schuell, Dassel, West Germany) (9).  The sheet was Ore- 
coated with bovine serum albumin and immersed overnight in ECCD-I solu- 
tion (containing 2  mM CaCl2) at room temperature. After washing in cold 
HBSS for 15 min, the sheet was treated with 1.75% glutaraldehyde in HBSS 
for 15 min at 4°C followed by another wash with HBSS for 15 rain. The sheet 
was again coated for I h with a 10% nonimmune  sheep serum diluted in HBSS, 
and then incubated with  I  #Ci/ml/lane ~25I-labeled sheep anti-rat Ig F(ab')2 
(Amersham International, Amersham, United Kingdom) in HBSS with 10% 
sheep serum. After washing with HBSS, the nitrocellulose sheet was processed 
for autoradiography. 
RESULTS 
Dissociation and Aggregation of Hepatocytes 
Liver cell cultures were used as a hepatocyte source through- 
out the  experiments.  Hepatocytes  were  distinguished  from 
fibroblastic  cells co-existing in the liver cell cultures, by im- 
munohistochemical staining with an antibody against alpha- 
fetoprotein which is known to be a marker  of hepatocytes in 
mouse fetus (10). 
It was difficult to dissociate the monolayers of liver cells 
into single cells by treatment with trypsin in the presence of 
Ca  2+ (TC-treatment). We found, however, that the treatment 
of liver cell cultures with collagenase in the presence of Ca  2+ 
prior to TC-treatment (collagenase-TC-treatment) facilitates 
the dissociation of cells, although most of cells still remained 
in  small clusters.  On the  other hand,  suspensions of single 
FIGURE  1  Aggregation of liver cells. (a-e) Collagenase-TC-treated 
cells: Cells before aggregation (a); cells incubated for 30 min in the 
presence of  1 mM  Ca  2+ without antibody (b),  with  anti-liver Fab 
(1.75  mg/ml)  (d)  and  with  ECCD-1  (diluted  1:10)  (e), and  in  the 
absence of Ca  2+ without antibody (c). (f) TE-treated cells incubated 
for 30 min in the presence of 1 mM Ca  2+. Bar, 150/zm. x  33. 
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presence of EGTA (TE-treatment) of the monolayers. 
Fig.  1  shows  the  aggregation  profile of liver cells.  Cells 
harvested by collagenase-TC-treatment aggregated into larger 
clusters in the presence of Ca  2÷ (Fig.  1 a  and b), but not in 
the absence of Ca  2÷ (Fig.  1 c). TE-treated cells did not aggre- 
gate under either condition (Fig.  I f). These results suggested 
the presence of typical Ca2+-dependent cell-cell adhesion sys- 
tems (CDS), which are resistant to protease in the presence of 
Ca  2÷ but not in the absence of Ca  2÷, in liver cells. 
Effect of Antibodies on Cell-Cell Adhesion 
Anti-liver Fab and ECCD-1 equally inhibited the aggrega- 
tion  of liver cells  dissociated  by  collagenase-TC-treatment 
(Fig.  1, d and e). This Fab also inhibited the aggregation of 
teratocarcinoma F9 and AT805 cells prepared by treatment 
with pronase and Ca  2÷ leaving their CDS intact (Fig. 2). 
These antibodies were added to monolayer cultures of liver 
cells and  AT805  cells.  Anti-liver caused  a  rounding-up  of 
hepatocytes (data not shown) and AT805 cells (Fig.  3, a and 
b),  apparently  disrupting  their  cell-cell  adhesion.  When 
ECCD-1 was added to the cultures of hepatocytes, the effect 
was not clear during the first few hours of incubation. How- 
ever, when the cells were cultured overnight with ECCD-1, a 
remarkable effect was observed. Colonies of hepatocytes were 
dispersed into smaller cell  clusters, although not into single 
cells (Fig.  3, c and d). Such an effect was most conspicuous 
when the antibody was added to the cells from the start of the 
cultures.  We  then  examined  which  cell  types in  liver cell 
cultures reacted with ECCD- 1 using an autoradiographic tech- 
nique. Fig. 4 shows that ECCD-1 binds only to hepatocytes, 
not to fibroblastic cells. 
Immunological Identification of Cell-Cell 
Adhesion Molecules 
Cell surface antigens reactive with anti-liver were collected 
from liver cells treated with trypsin in the presence of Ca  2÷ 
(TC) or EGTA (TE), by immunoprecipitation. Fig.  5, a  and 
b  show  that  one cell  surface  protein with  an  approximate 
molecular  weight  of  124,000  (124-kdalton  component)  is 
present only in TC-treated cells. The molecular weight of this 
protein was the same as that of "p140" identified as a com- 
ponent of CDS in  teratocarcinoma cells using an  antibody 
raised against F9 cells (anti-TC-F9) in our previous work (3). 
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FIGURE  2  Effect  of anti-liver Fab  on  aggregation of AT805  cells 
treated with pronase and Ca  2+. Cells were incubated for 30 min in 
the presence of 1 mM Ca  2+ and various concentrations of anti-liver 
Fab. The  degree of  inhibition of aggregation was calculated as 
described elsewhere (6). 
FIGURE  3  Effect  of antibodies on monolayer cultures of cells. AT805 cells were incubated for 4 h without (a) and with (b) anti- 
liver Fab (2 mg/ml). Liver cells were cultured overnight without (c) and with (d) ECCD-I (diluted 1:5). In c and d, alpha-fetoprotein 
was stained to identify hepatocytes: The cultures were fixed with absolute methanol at -20°C and incubated with rabbit anti- 
mouse alpha-fetoprotein diluted  1:20  (Miles  Laboratories,  Elkhart,  IN),  then  with  goat anti-rabbit  IgG  diluted  1:10  (Cappel 
Laboratories, Cochranville, PA), and finally with rabbit peroxidase-anti-peroxidase  diluted 1:50 (Cappel Laboratories), all of which 
were diluted with PBS. The bound antibodies were detected by staining as described by Boenisch (I 5). (a and b), phase contrast 
microscopy; (c and o0, transmitted light microscopy. Bars, 100/~m. (a and b), x  100; (c and d}, x  126. 
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cell culture.  Cells were incubated in ECCD-1 solution diluted 1:4 
(containing 2 mM CaCI2)  for 30 min at 4"C, and after washing with 
cold HBSS, they were incubated with 1 u.Ci/m112Sl-labeled  anti-rat 
lg F(ab')2 in HBSS for 30 min. After washing with HBSS, the cells 
were fixed with 2% glutaraldehyde in HBSS  and washed again with 
HBSS, followed by a coating  with Sakura autoradiographic  emulsion 
NR-M2. A portion of a enclosed by a square was enlarged in b in 
which  photographs were  focused  on  silver  grains.  H  indicates 
hepatocytes and F indicates  fibroblastic cells.  Cells were stained 
with Giemsa's solution. Bar, 25/~m. (a) x  167; (b) x  540. 
was the major cell surface antigen reactive with anti-liver. The 
124-kdalton component was also detected in TC-treated and 
nontrypsinized  F9  and  ATS05  cells as an  antigen  reacting 
with anti-liver but not in TE-treated cells (data not shown). 
In detecting the target molecules for ECCD-1, the immu- 
noprecipitation technique used in the above experiments was 
not applicable as described elsewhere (C. Yoshida-Noro, N. 
Suzuki, and M. Takeichi, manuscript submitted), so we uti- 
lized "Western blots." As an antigen source for this analysis, 
the whole cell lysate was not useful, since it did not contain 
amounts of antigen detectable by ECCD-1. To prepare con- 
centrated antigen samples, we collected cell surface molecules 
immunoreacting with anti-liver from monolayer cultures of 
F9  and  liver cells by the  same  method  used  in  the  above 
experiments (except that the cells were not radiolabeled), and 
used them  for Western  blot  analysis. The rationale  of this 
method was based on the assumption that the target mole- 
cule(s) for ECCD-1  would be one(s) of those for anti-liver, 
and  this was supported by the  observation that binding  of 
radiolabeled  ECCD-1  to  cell  surfaces  is  inhibited  by  the 
presence of anti-liver (data not shown). 
Fig. 5 d shows that ECCD- 1 binds to multiple bands in the 
sample of F9 cells, bands I (mol wt  124,000)  and II (mol wt 
104,000)  being the first and second major components, re- 
spectively, The molecular weight of band I corresponded to 
the 124-kdalton band detected in the above experiment. This 
was consistent with results obtained using an antibody raised 
against  F9  cells  to  collect  cell  surface  antigens,  described 
elsewhere (C.  Yoshida-Noro,  N.  Suzuki,  and  M.  Takeichi, 
manuscript submitted). 
In liver, ECCD- 1 reacted with the same components (bands 
I and II) as in F9 cells (Fig.  5, e and f). However, the ratio of 
bands I and II varied from experiment to experiment, i.e., in 
some cases, band I was the major component and in  other 
cases, band lI was. It appeared that the amounts of these two 
components were present in inverse proportions. 
FIGURE 5  Detection of antigens  reacting  with  anti-liver (A) and 
ECCD-1 (B). In A, antigen samples were collected from TC-treated 
liver cells, (a), TE-treated liver cells (b),and monolayers of liver cells 
(c). In B, antigens were collected from monolayers of F9 cells (d) 
and of liver cells (e and f). Molecular weight markers were G, f.. coli 
~-galactosidase  (116,000);  P,  phosphorylase-b (94,000);  A,  BSA 
(68,000). Positions of these markers are shown only for A. 
also found to be specific to TC-treated cells. When the antigen 
samples were collected from nontrypsinized monolayer cul- 
tures  of liver cells,  the  124-kdalton  component was  again 
detected (Fig.  5 c). Interestingly, this 124-kdalton component 
DISCUSSION 
The results described in this paper showed that hepatocytes 
in  mouse  liver have Ca2+-dependent cell-cell  adhesion  sys- 
tems, as found in various other cell types. The analysis of cell- 
cell  adhesion  in  hepatocytes,  however,  seems to  be  more 
complicated than  that  in  other  cells studied  thus  far,  i.e., 
fibroblasts (4),  neural  retina cells (6),  and  teratocarcinoma 
cells (2). It was difficult to prepare a suspension of single liver 
cells retaining intact CDS by treatment with protease solutions 
containing Ca  2÷. Consistent  with this  finding,  ECCD-I  did 
not completely dissociate colonies of hepatocytes into single 
cells  in their monolayer cultures, indicating the presence of 
another mediator(s) for cell-cell  adhesion.  These mediators 
could be tight junctions, other junctional structures, or some 
unknown  molecules in  Ca2÷-independent cell-cell  adhesion 
systems. Even if there are several different cell-cell  adhesion 
mediators in  hepatocytes, it seems certain that CDS play a 
major role in maintaining the physiological functions of the 
tissues based on  cell-cell  adhesion.  Thus,  we observed that 
animals receiving an injection of ECCD-1 or the hybridoma 
producing  ECCD-1  into  the  peritoneal  cavity  die  shortly 
afterwards (unpublished data). 
Immunological analysis in the present study showed that 
CDS in hepatocytes and teratocarcinoma cells are composed 
of  essentially the same components. Two classes of  cell surface 
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also  detected  in  liver.  This  suggests  that  the  other  tissues 
reacting with ECCD-1, such as epidermis, are also provided 
with  the  same adhesion  molecules.  Since  ECCD-I  reacted 
with various tissues,  always affecting their cell-cell  adhesion 
(C.  Yoshida-Noro, N. Suzuki, and M. Takeichi, manuscript 
submitted),  the  molecules  identified  in  the  present  study 
should be of  general importance to cell-cell adhesion in many 
kinds of cells.  Although  the  124-kdalton (and  104-kdalton) 
components are probably the major constituents of CDS in 
the tissues studied here, we cannot rule out the possibility of 
the presence of other components of CDS recognizable by 
ECCD-1,  since we detected antigens reactive with ECCD-I 
only from materials immunopreciptated with anti-liver. 
We observed some difference between liver and temtocar- 
cinoma  in  the  electrophoretic  pattern  of antigens  reacting 
with ECCD-1. In teratocarcinoma, band I was the predomi- 
nant component in the Western blot. On the other hand, in 
liver, band I was sometimes detected as a minor component 
and  was  even  undetectable  in  some  electrophoretic  runs, 
whereas band  II became prominent as band I  diminished. 
The most reasonable explanation would be to assume that 
band II is a degradation product of band I. Although protease 
inhibitors were always included in the solutions for extraction 
of antigens, certain classes of proteolytic enzymes might be 
able to cleave the band I component into smaller molecules 
under  certain  conditions.  Teratocarcinoma cells  may have 
less of such enzymes. 
The present results are consistent with the recent findings 
of Gallin  et  al.  (l 1).  They  characterized  a  cell  adhesion 
molecule involved in chick embryonic liver, termed L-CAM. 
The molecular weight of a major component recognized by 
antibodies against L-CAM was  124,000.  L-CAM showed a 
Ca2+-sensitive  property when cleaved with proteases. Thus, 
the overall properties of L-CAM are quite similar to those of 
the  Ca2+-dependent  cell  adhesion  molecules studied  here. 
Although we did not detect a tryptic fragment with a molec- 
ular weight of 81,000  as described in their paper, and they 
did  not  detect  a  component corresponding to band  II de- 
scribed in the present study, the discrepancy between these 
results could only be due to the difference in the method of 
detection of antigens. Gallin et al. (I 1) also reported that L- 
CAM is not detected in fibroblasts, consistent with our find- 
ings. We can, therefore, conclude that mammalian and avian 
cells are provided with Ca2+-dependent cell-cell adhesion mol- 
ecules of the same molecular weight and probably with the 
same cell-type-specificity. 
Ocklind et al.  (12)  have suggested the  involvement of a 
glycoprotein with a  molecular weight of 105,000  (cell-CAM 
105)  in  rat  hepatocyte cell-cell  adhesion.  This  molecule is 
quite similar in size to band II of our present study, suggesting 
an identity for these two molecules. If the adhesion system 
that these authors investigated was identical to the one we 
studied,  they should have found the band I component.  It 
might, however, be that this component is easy to miss owing 
to degradation during preparation of samples. On the other 
hand, Ocklind et al. (13) recently reported that an antibody 
against  cell-CAM  105  does  not  react  with  skin,  whereas 
ECCD-1  strongly reacted with  epidermis of this  tissue  (C. 
Yoshida-Noro, N. Suzuki, and M. Takeichi, manuscript sub- 
mitted), suggesting the possibility that these antibodies may 
recognize the different antigens. 
ECCD-I  selectively  reacted  with  hepatocytes  and  other 
epithelial cells,  but not with fibroblastic cells,  in cultures of 
various tissues, as shown in the present and other studies (C. 
Yoshida-Noro, N. Suzuki, and M. Takeichi, manuscript sub- 
mitted). The cell adhesion molecules described here, therefore, 
should work only for connecting particular cell types. Previous 
studies demonstrated that fibroblastic cells also have CDS but 
with different functional and immunological specificities from 
those in teratocarcinoma cells (2). We also showed that mouse 
embryos at cleavage stage, even at one-cell stage, are provided 
with CDS of the same specificity as in teratocarcinoma cells 
(14). Therefore, a lineage of cells with ECCD-l-sensitive CDS 
is initiated at the start of embryonic development and contin- 
ues to  late  developmental  stage  (probably to  adult  stage), 
being inherited  by certain  classes of epithelial  cells.  Other 
lineages of cells with CDS of different specificities,  such as 
fibroblasts, must be generated by diverging from this initiative 
lineage. It will be the important subject in future studies to 
elucidate the developmental significance and the genetic con- 
trol  mechanisms  of such  divergence  of cell  lineages  with 
different types of CDS. 
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